BodyM
Stay steady on GLP-1s.
Learn by the problem you have now.

Plain GLP-1 guides for side effects, dose changes, food, recovery, and support products.

Log inCreate accountStart a post
GLP KeepFit knowledge library

Detailed GLP-1 guidance, organized by real user questions.

This is the structured reference layer for GLP KeepFit. It covers starting fit, drug and brand differences, side-effect timing, symptom-by-symptom solutions, stopping and restarting, and the main GLP support products users already compare.

Pages
20
Clear guides for the questions people ask most often.
Structure
6
Start, dose changes, side effects, food, recovery, and product comparisons.
Best use
Read by problem first.
Pick the question you are facing now, then open the most relevant guide.
Browse by category
All pagesStart Here1Drugs & Brands1Side Effects & Timeline2Symptom Solutions12Stopping & Restarting3App & Brand Comparisons1

Start with the question you are trying to answer. Each page gives practical context, simple checks, and sources where accuracy matters.

Quick reference

How this library is organized

Major weight-loss GLP drugs at a glance

PathCadenceMain watch windowKey journey difference
Wegovy / semaglutideWeeklyWeeks 1-20Higher cumulative GI burden, especially around start and escalation
Zepbound / tirzepatideWeeklyWeeks 1-24Longer standard climb creates more transition windows to support
Saxenda / liraglutideDailyWeeks 1-8Daily injection cadence creates a different adherence rhythm

Highest-value symptom windows

WindowWhat commonly happensWhat support should do
Pre-startFear of side effects and uncertainty about fitExplain fit, baseline checks, and first-week expectations
First 72 hoursNausea, low intake, new meal intoleranceTighter check-ins and simpler food / hydration guidance
Each dose increaseNew symptom spike or confidence dropEscalation-aware watch window with practical next steps
Weeks 2-24Constipation, reflux, lingering GI dragLonger-run rhythm management and supplement fit

Main product groups users already compare

GroupWhat it solves bestWhat it often misses
Telehealth access platformsFast evaluation and prescription routingDay-to-day GI retention support
Behavior / community productsHabit structure and accountabilityDetailed symptom operations and escalation logic
Supplement / nutrition playersProduct shelf and category depthIntegrated clinical workflow and dose-phase logic
Start Here10 min readApr 17, 2026

Starting GLP-1: eligibility, contraindications, and baseline checks

A structured before-you-start page covering who typically uses GLP-1s for weight management, what needs prescriber review first, and what a serious support product should capture before day one.

This page includes
  • Who usually fits GLP-1 weight-management treatment and who needs more review first
  • Which contraindications and caution situations should already be known before day one
  • Which baseline GI, intake, and hydration patterns are worth capturing before appetite drops
  • What a companion system should have ready before the first dose window starts
Key data point
3
Foundational layers: fit, risk review, and baseline tracking
start hereeligibilitycontraindications
Read page
Drugs & Brands11 min readApr 17, 2026

GLP-1 drug and brand comparison: Wegovy, Ozempic, Zepbound, Mounjaro, Saxenda

A practical comparison of the major GLP-1 and GIP/GLP-1 drugs users ask about most: how the molecules differ, what the branded labels mean, which titration windows are longest, and where GI burden tends to show up.

This page includes
  • Which brands map to which molecules and indications
  • How semaglutide, tirzepatide, and liraglutide differ in cadence and escalation length
  • Which drugs show the heaviest GI burden signals in obesity labeling
  • Why users should compare molecule plus support path, not just brand popularity
Key data point
20 wk
Tirzepatide standard climb to 15 mg in obesity treatment
drug comparisonWegovyZepbound
Read page
Side Effects & Timeline8 min readApr 16, 2026

GLP-1 side effects timeline: what tends to show up, when, and why

A practical week-by-week view of common GLP-1 side effects, the dose-escalation windows that tend to feel hardest, and the signals that should not be ignored.

This page includes
  • Which symptoms typically show up at start versus after a dose increase
  • Which GI problems usually peak early and which ones linger for weeks
  • What week 1 to week 24 usually looks like in real tolerability terms
  • Which symptom patterns should move a user out of self-guided support
Key data point
44%
Adult Wegovy trial participants reporting nausea
GI timelinedose escalationnausea
Read page
Side Effects & Timeline6 min readApr 16, 2026

The first 72 hours after a GLP-1 dose increase

A simple operating window for the first three days after a dose increase, including what to watch, what to lower, and when to stop guessing.

This page includes
  • What to watch in the first three days after moving up a dose
  • How to simplify food, fluids, and check-ins before a week spirals
  • Which symptoms justify calling the prescriber instead of guessing
Key data point
72h
Most useful watch window after a step-up
72 hoursdose increaseGI protocol
Read page
Symptom Solutions6 min readApr 19, 2026

GLP diarrhea support: what helps when hydration and intake start sliding

A practical guide for GLP-1 diarrhea, loose-stool days, and the hydration drop-off that can quietly turn a tolerability issue into a continuity problem.

This page includes
  • Diarrhea is less discussed than constipation, but it can disrupt the journey faster because it drains fluids, electrolytes, and confidence at the same time.
  • The first useful question is usually not which product stops it instantly. It is whether the user is now under-hydrated, under-fueled, or both.
  • The more diarrhea overlaps with vomiting, dizziness, severe weakness, fever, or intense pain, the less appropriate it is to keep treating it like a routine side effect.
Key data point
Hydration first
The main risk is often not the stool pattern alone, but what it does to intake and recovery
diarrheahydrationelectrolytes
Read page
Symptom Solutions6 min readApr 19, 2026

GLP hair loss support: why shedding shows up and what actually matters first

A practical guide to GLP-related hair shedding, telogen effluvium patterns, and the support moves that make more sense than chasing a cosmetic miracle stack.

This page includes
  • Hair loss is one of the most emotional GLP side effects, but it is usually better framed as a downstream stress signal than as a stand-alone cosmetic event.
  • Public discussion is clear on one thing: protein and overall nutritional adequacy come before any beauty-angle supplement.
  • Collagen is discussed constantly, but it works best as a secondary support layer rather than the core explanation for why shedding started.
Key data point
Delayed signal
Hair shedding often lags behind the intake or rapid-weight-loss stress that triggered it
hair losstelogen effluviumprotein
Read page
Symptom Solutions6 min readApr 19, 2026

GLP low appetite and protein shortfall: what helps before intake falls too far

A practical guide for GLP-1 users who are eating less than expected, missing protein, and trying to avoid turning appetite suppression into a longer recovery problem.

This page includes
  • Low appetite sounds like the expected mechanism of GLP-1 drugs, but it becomes a real product problem when protein starts collapsing with it.
  • Users often do not need a larger meal plan. They need an easier way to keep enough protein in the day without making nausea, heaviness, or food aversion worse.
  • This is one of the strongest pages for premium companion logic because the answer is sequencing, not more motivation.
Key data point
Protein first
One of the clearest product-fit problems in the whole GLP category
low appetiteproteinintake
Read page
Symptom Solutions6 min readApr 19, 2026

GLP vomiting and dehydration: what helps before the week turns unsafe

A practical guide for GLP-1 vomiting, poor fluid tolerance, and dehydration risk, including what belongs in self-guided support and what should escalate faster.

This page includes
  • Vomiting changes the problem. Once fluids stop staying down, the issue is no longer only comfort. It is stability.
  • The most useful first-line support moves are hydration-focused and low-friction, but this is also one of the clearest places where escalation boundaries matter.
  • A trustworthy support page should help the user recover when the picture is still mild and push them out of self-management when it is not.
Key data point
Faster risk
This is where routine discomfort can become a real continuity and safety problem quickly
vomitingdehydrationelectrolytes
Read page
Symptom Solutions7 min readApr 19, 2026

GLP-1 muscle retention: what actually helps before strength starts slipping

A practical muscle-retention guide for GLP-1 users who are losing weight but do not want lean mass, strength, and recovery to quietly disappear with it.

This page includes
  • GLP-1 users do not only lose weight. They can also lose lean mass if protein, resistance stimulus, and recovery all drift too low.
  • This is one of the clearest places where companion support can be premium: the user needs structure, not generic motivation.
  • The strongest first-line strategy is usually protein adequacy plus simple resistance consistency. Creatine is the cleanest secondary add-on.
Key data point
Lean mass
One of the most important downstream variables to actively protect
muscle retentionproteincreatine
Read page
Symptom Solutions6 min readApr 17, 2026

GLP dizziness and weakness: when the real issue is low intake, low fluids, or both

A support guide for light-headedness, weakness, and low-intake fatigue on GLP-1s, including what to check first and when the symptom cluster should stop being self-managed.

This page includes
  • Why dizziness often points to low intake, low fluids, or both
  • How to spot the difference between temporary fatigue and an intake problem
  • Which same-day signals should escalate instead of being normalized
Key data point
Secondary signal
Often a downstream sign of low fluids, low intake, or GI loss
dizzinessweaknesslow intake
Read page
Symptom Solutions5 min readApr 17, 2026

GLP GI discomfort score: a fast self-check for when the week starts turning

A simple support score for nausea, vomiting, constipation, reflux, hydration, energy, and abdominal pain that helps separate mild friction from a higher-risk symptom picture.

This page includes
  • A quick user-facing way to judge whether the current day is mild, building, or no longer safe to downplay
  • What questions matter more than generic symptom labels
  • How to move from score to next action instead of vague reassurance
Key data point
8 signals
Used to map whether the last 24 hours still look routine
self-checkGI scoretriage
Read page
Symptom Solutions6 min readApr 17, 2026

GLP reflux, bloating, and burps: the upper-GI friction that gets underestimated

Why reflux, bloating, fullness, and burping keep showing up on GLP-1s, what usually helps first, and what should make the user stop treating it like a small comfort issue.

This page includes
  • How upper-GI heaviness differs from classic nausea
  • Which meal patterns usually trigger reflux and bloating
  • What to change first before buying more products
Key data point
Upper GI
A symptom cluster that quietly makes adherence feel harder
refluxbloatingburps
Read page
Symptom Solutions7 min readApr 17, 2026

GLP supplement scorecard: what deserves attention first and what should stay off the hero shelf

A practical scorecard for protein, hydration support, fiber, ginger, probiotics, magnesium, and other common GLP-related supplement categories.

This page includes
  • Which supplement categories are actually relevant to nausea, constipation, low intake, and hydration
  • How to separate symptom-fit from broad marketing claims
  • Which categories are reasonable first purchases and which ones need more caution
Key data point
A-tier
Protein, hydration support, fiber, and ginger are the strongest early-fit categories
supplementsproteinelectrolytes
Read page
Symptom Solutions12 min readApr 17, 2026

GLP-1 side-effect solutions matrix: nausea, constipation, reflux, diarrhea, low intake

A single operational page that maps the most important GLP side effects to likely timing windows, food shifts, supplement layers, psychological expectations, and escalation thresholds.

This page includes
  • A symptom-by-symptom matrix covering timing, first-line food moves, supplement fit, and escalation thresholds
  • Practical expectations for nausea, constipation, reflux, diarrhea, and low-intake weakness
  • A way to connect discomfort to next action instead of generic reassurance
  • Clear boundaries between a rough but manageable phase and a red-flag event
Key data point
6
Core symptom clusters most likely to affect comfort and retention
solutions matrixnauseaconstipation
Read page
Symptom Solutions7 min readApr 16, 2026

GLP-1 constipation: the symptom most likely to drag on

Why constipation becomes one of the longest-running GLP-1 complaints, what support usually makes sense first, and what signs should change the response.

This page includes
  • Why constipation often becomes the longest-running GLP complaint
  • How water, intake level, fiber fit, and activity interact
  • When constipation stops being a nuisance and becomes a red-flag branch point
Key data point
24%
Adult Wegovy trial participants reporting constipation
constipationfiberhydration
Read page
Symptom Solutions7 min readApr 16, 2026

What helps GLP-1 nausea without turning it into guesswork

A practical framework for GLP-1 nausea: what usually makes it worse, what often helps first, and when the symptom is no longer a routine adjustment issue.

This page includes
  • What usually worsens nausea during a GLP start or step-up phase
  • What changes in food form, portion, and pace help first
  • How to tell routine nausea from the start of a dehydration problem
Key data point
1
Most common early dropout trigger to design around
nauseafood aversionprotein
Read page
Stopping & Restarting6 min readApr 17, 2026

Can you restart GLP-1 after stopping? Yes, but restart is not something to freestyle

A restart-focused guide for users coming back to GLP-1s after a pause, including why time off matters, why jumping back to the old high dose is risky, and what support needs to change.

This page includes
  • Why a restart should not be treated like a simple continuation
  • What to review before re-entry after a pause
  • How to lower the chance of repeating the first bad tolerability cycle
Key data point
2+ doses
A missed-dose threshold specifically called out in the Wegovy label
restart glp-1missed dosesrestart dosing
Read page
Stopping & Restarting7 min readApr 17, 2026

What happens when you stop GLP-1? Appetite rebound, regain pressure, and what usually changes first

A practical off-ramp guide for what tends to change after stopping GLP-1s, including appetite rebound, regain pressure, and what helps users plan the next phase earlier.

This page includes
  • What usually changes first after a GLP-1 stop
  • Why appetite and decision friction often return before users are psychologically ready
  • Which support moves matter once the prescription pauses
Key data point
2/3
Prior weight loss regained within a year in the STEP 1 extension
stop glp-1appetite reboundweight regain
Read page
Stopping & Restarting8 min readApr 16, 2026

Stopping GLP-1, restarting later, and why this is not just a willpower problem

A practical view of why people stop, what changes after stopping, and why off-ramp support is part of the product, not an afterthought.

This page includes
  • Why stopping is common and should be treated as part of the real journey
  • What makes restart attempts harder when the first run went poorly
  • What a support layer should do before, during, and after a pause
Key data point
50-75%
12-month interruption range seen in real-world studies
off-ramprestartadherence
Read page
App & Brand Comparisons10 min readApr 17, 2026

GLP-1 companion product comparison: Noom, WW, Found, Ro, Hims, Mochi, Form

A practical comparison of the main U.S. GLP companion and telehealth products, focused on what users actually compare: prescription access, GI support depth, AI layer, supplement logic, and operational friction.

This page includes
  • What the main U.S. GLP products actually do well and where they still leave users unsupported
  • Which products are strongest on clinical workflow, maintenance, community, or supplement commerce
  • Why GI-first retention support is still not fully owned by a single player
  • How to compare app experience, support depth, and operating friction without mixing them up
Key data point
0
Current major players fully owning GI-first support plus AI plus supplement fit plus strong workflow
market comparisonNoomWeightWatchers
Read page